Pharmanutra S.p.A. (FRA:761)

Germany flag Germany · Delayed Price · Currency is EUR
74.60
-1.10 (-1.45%)
At close: Mar 27, 2026
Market Cap717.36M +39.4%
Revenue (ttm)133.97M +15.3%
Net Income20.00M +20.4%
EPS2.09 +20.9%
Shares Outn/a
PE Ratio35.86
Forward PE29.28
Dividend1.00 (1.34%)
Ex-Dividend DateMay 5, 2025
Volumen/a
Average Volume22
Open74.60
Previous Close75.70
Day's Range74.60 - 74.60
52-Week Range38.55 - 75.70
Betan/a
RSI68.22
Earnings DateMay 14, 2026

About Pharmanutra

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, Europe, the Middle East, South America, Far East, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It also offers iron deficiency, inflammation, mineral and vitamin, muscle and joint, sports nutrition, ophthalmic, and night rest products; and medical instrumentation and softwar... [Read more]

Industry Pharmaceutical Preparations
Founded 2003
Employees 136
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 761

Financial Performance

In 2025, Pharmanutra's revenue was 133.97 million, an increase of 15.34% compared to the previous year's 116.15 million. Earnings were 20.00 million, an increase of 20.43%.

Financial Statements